Abstract:Aptamers are DNA or RNA oligonucleotide sequences that selectively bind to their target with high affinity and specificity. They are obtained using an iterative selection protocol called SELEX. Several small molecules and proteins have been used as targets. Recently, a variant of this methodology, known as cell-SELEX, has been developed for a new generation of aptamers, which are capable of recognizing whole living cells. We have used this methodology for the selection of aptamers, which show high affinity and specificity for several cancer cells. In this chapter, we describe (1) the process followed for the generation of aptamers capable of recognizing acute leukemia cells (CCRF-CEM cells) and (2) the method of enhancing the selectivity and sensitivity of these aptamers by conjugation with a dual-nanoparticle system, which combines magnetic nanoparticles (MNP) and fluorescent silica nanoparticles (FNP). Specifically, the selected aptamers, which showed dissociation constants in the nanomolar range, have been coupled to MNPs in order to selectively collect and enrich cells from complex matrices, including blood samples. The additional coupling of the aptamer to FNPs offers an excellent and highly sensitive method for detecting cancer cells. In order to prove the potential of this rapid and low-cost method for diagnostic purposes, confocal microscopy was used to confirm the specific collection and detection of target cells in concentrations as low as 250 cells. The final fluorescence of the cells labeled with the nanoparticles was quantified using a fluorescence microplate reader.

Synthesis of Magnetic and Fluorescent Bifunctional Nanocomposites and Their Applications in Detection of Lung Cancer Cells in Humans.

A Point-of-care Testing System with Love-wave Sensor and Immunogold Staining Enhancement for Early Detection of Lung Cancer

Multifunctional fluorescent magnetic nanoparticles for lung cancer stem cells research

A novel magnetic fluorescent biosensor based on graphene quantum dots for rapid, efficient, and sensitive separation and detection of circulating tumor cells

Ultrasonication-assisted one-step self-assembly preparation of biocompatible fluorescent-magnetic nanobeads for rare cancer cell detection

Dual-Color Fluorescence Imaging of Magnetic Nanoparticles in Live Cancer Cells Using Conjugated Polymer Probes

Fluorescent/Magnetic Nanoprobes of High Specificity for Detection of Triple Negative Breast Cancer

Engineering Supramolecular Ensemble for Specific Distinction of Lung Adenocarcinoma from Inflammation

Synthesis of Immunomagnetic Nanoparticles and Their Use for Breast Cancer Cell Separation

Pattern Recognition of Cancer Cells Using Aptamer-Conjugated Magnetic Nanoparticles.

Magnetic copper silicate and boronic acid-conjugated AuNCs@keratin-based electrochemical/fluorescent dual-sensing for carcinoembryonic antigen

Nanoparticle-aptamer conjugates for cancer cell targeting and detection.

Anti-CD155 and anti-CD112 monoclonal antibodies conjugated to a fluorescent mesoporous silica nanosensor encapsulating rhodamine 6G and fluorescein for sensitive detection of liver cancer cells.

Competitive Aptasensor for the Ultrasensitive Multiplexed Detection of Cancer Biomarkers by Fluorescent Nanoparticle Counting.

Sensitive detection of carcinoembryonic antigen with magnetic nano-bead and upconversion nanoparticles-based immunoassay.

Gradient Magnetic Separation and Fluorescent Imaging‐Based Heterogeneous Circulating Tumor Cell Subpopulations Assay with Biomimetic Multifunctional Nanoprobes

Dual Immunomagnetic Nanobeads-Based Lateral Flow Test Strip for Simultaneous Quantitative Detection of Carcinoembryonic Antigen and Neuron Specific Enolase.

A Facile Method to Prepare High-Performance Magnetic and Fluorescent Bifunctional Nanocomposites and Their Preliminary Application in Biomolecule Detection.

A Novel Lanthanide-Based NIR-II Nanoprobe for Lung Squamous Cell Carcinoma Identification

Magnetic bead-based AuNP labelling combined with inductively coupled plasma mass spectrometry for sensitively and specifically counting cancer cells

Aptamer-Conjugated Nanoparticles for Selective Collection and Detection of Cancer Cells